亲子辅助计划随机对照试验研究方案:针对孕期物质使用者的个案管理与家访项目
本研究为一项随机对照试验方案,旨在检验亲子辅助计划(PCAP)相较于常规服务在改善孕期有风险物质使用者的物质使用与家庭规划相关主要结局方面的有效性。研究将在俄克拉荷马州两个都市区招募200名孕期或产后24个月内、当前或最近一次妊娠期间存在有风险物质使用的分娩个体,按地点分层随机分配接受PCAP或常规服务3年,基线及12、24、36个月时评估主要和次要结局。
要点
- PCAP是为期3年的个案管理与家访干预,旨在帮助孕期有风险物质使用者实现并维持物质使用障碍康复。
- 研究采用意向性治疗设计,招募200名孕期或产后24个月内、当前或最近一次妊娠有风险物质使用的分娩个体。
- 参与者按地点分层随机分配接受PCAP或常规服务3年,主要结局在基线及12、24、36个月评估。
核心结论
- 该试验结果将有助于评估PCAP在改善亲子福祉方面的有效性,并供联邦家访与寄养预防审查机构判定证据强度,进而影响州级联邦资助。
研究设计与样本
- 采用意向性治疗设计的随机对照试验,从俄克拉荷马州两个都市区招募200名孕期或产后24个月内、当前或最近一次妊娠期间存在有风险物质使用的分娩个体。
- 参与者按地点分层随机分配接受PCAP或常规服务,干预持续3年。
- PCAP组参与者约每两周与个案管理员在其所在社区或家中会面,个案管理员协助设定目标并提供实际帮助。
- 主要和次要结局在基线及基线后12、24、36个月通过成瘾严重指数访谈和自填问卷评估。
主要发现
- 原文未报告试验结果。
关键数值与推荐
- 主要结局涉及物质使用与家庭规划。
- 次要结局涉及与康复支持服务的连接及家庭保全。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perinatal substance use can have significant adverse effects on maternal and child health and family stability. Few interventions are specifically designed to address this significant public health problem. The Parent-Child Assistance Program (PCAP) is a 3-year case management and home-visiting intervention that seeks to help birthing persons with at-risk substance use during pregnancy to achieve and maintain substance use disorder recovery and avoid exposing future children to substances prenatally. At-risk refers to a level of substance use that creates problems in the individuals' lives or puts them or their children at risk of harm either prenatally or postnatally. Although the program has consistently shown substantial pre- to post-intervention improvements in its participants, PCAP remains to be tested with a rigorous randomized controlled trial (RCT). This study protocol describes a randomized controlled trial that aims to examine the effectiveness of the intervention compared to services as usual in affecting primary outcomes related to substance use and family planning. Secondary outcomes will concern connection to recovery support services and family preservation. METHODS: Using an intent-to-treat design, the study will recruit from two metro areas in Oklahoma and enroll 200 birthing individuals who are pregnant or up to 24 months postpartum with at-risk substance use during their current or most recent pregnancy. Participants will be randomly assigned, stratified by location, to receive either PCAP or services as usual for 3 years. Participants in the PCAP condition will meet with their case manager approximately biweekly over the course of the intervention period, in their local communities or in their own homes whenever possible. Case managers will assist with goal setting and provide practical assistance in support of participants' goals. Primary and secondary outcomes will be assessed at baseline and 12, 24, and 36 months post-baseline using the Addiction Severity Index interview and a self-administered survey. DISCUSSION: Results from this trial will help to gauge the effectiveness of PCAP in improving parent and child well-being. Results will be reviewed by federal clearinghouses on home-visiting and foster care prevention to determine the strength of evidence of effectiveness with implications for federal financing of this program model at the state level. TRIAL REGISTRATION: ClinicalTrials.gov NCT05534568. Registered on 6/8/2022.
引用
- Maher EJ, Stoner SA, Gerlinger J, et al. Study protocol for a randomized controlled trial of the Parent-Child Assistance Program: a case management and home visiting program for people using substances during pregnancy. Trials. 2024. PMID: 38627843. doi:10.1186/s13063-024-08098-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。